Showing results (1061-1070 of 1,138) with videos related to

Sort By:
Pageof 114
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 8, 2019
Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forwardCornelia Adlhoch, Zdenka Manďáková, Steen Ethelberg, et al.
Journal of Pathology Informatics|March 11, 2026
The critical role of standards for AI in digital pathology: Digital Pathology Association Concept PaperChhavi Chauhan, Anil Parwani, Vanessa Schumacher, et al.
Arquivos Brasileiros De Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery|November 12, 2025
Global strategies for the diffusion of robotic surgeryFrancisco Tustumi, Louisa Bolm, Rodrigo Camargo Leão Edelmuth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2025
Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 StudyRoy S Herbst, Byoung Chul Cho, Caicun Zhou, et al.
Journal of the American Heart Association|February 19, 2016
Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human DiseaseSperanza Rubattu, Sara Di Castro, Herbert Schulz, et al.
JMIR Research Protocols|May 31, 2022
The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort StudyKatherine E Halliday, Patrick Nguipdop-Djomo, William E Oswald, et al.
The New England Journal of Medicine|November 8, 2023
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLCDavid Planchard, Pasi A Jänne, Ying Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.
Pageof 114